Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To allow for long-term expression in dividing cells, a dual NILV vector system was developed to include the integrase of phage phiC31 [91].”
From Clinical use of lentiviral vectors (2018) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210 · cited 1×
“Recent strategies to tackle this challenge are relying on the use of genome editing tools such as ZFNs [2–7], TALENs [8–13] or more recently CRISPR-Cas system [14–17].”
MethodIn Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 3×
“In contrast, lentiviral vectors (LV) have the advantage to be non-immunogenic [73,74] and offers the possibility to be pseudotyped by different envelops, allowing a high degree of flexibility regarding the tropism of the particles and the type of cell(s) they transduce (for review see Cronin J.”
BackgroundMethodLMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Efficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., Lahaye, T., Nickstadt, A., & Bonas, U. (2009) · Science · doi:10.1126/science.1178811 · Cited by 2,470
A Simple Cipher Governs DNA Recognition by TAL Effectors
Moscou, M. J., & Bogdanove, A. J. (2009) · Science · doi:10.1126/science.1178817 · Cited by 1,988
An optimized transgenesis system for Drosophila using germ-line-specific φC31 integrases
Bischof, J., Maeda, R. K., Hediger, M., Karch, F., & Basler, K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611511104 · Cited by 1,866
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Urnov, F. D., Miller, J. C., Lee, Y.-L., Beausejour, C. M., Rock, J. M., Augustus, S., Jamieson, A. C., Porteus, M. H., Gregory, P. D., & Holmes, M. C. (2005) · Nature · doi:10.1038/nature03556 · Cited by 1,641
Raper, S. E., Chirmule, N., Lee, F. S., Wivel, N. A., Bagg, A., Gao, G.-P., Wilson, J. M., & Batshaw, M. L. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.08.016 · Cited by 1,498
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., Mayford, M., Kandel, E. R., & Tonegawa, S. (1996) · Cell · doi:10.1016/s0092-8674(00)81826-7 · Cited by 1,280
Genetic engineering of human pluripotent cells using TALE nucleases
Hockemeyer, D., Wang, H., Kiani, S., Lai, C. S., Gao, Q., Cassady, J. P., Cost, G. J., Zhang, L., Santiago, Y., Miller, J. C., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1927 · Cited by 1,135
Hockemeyer, D., Soldner, F., Beard, C., Gao, Q., Mitalipova, M., DeKelver, R. C., Katibah, G. E., Amora, R., Boydston, E. A., Zeitler, B., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1562 · Cited by 1,056
Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases
Geurts, A. M., Cost, G. J., Freyvert, Y., Zeitler, B., Miller, J. C., Choi, V. M., Jenkins, S. S., Wood, A., Cui, X., Meng, X., et al. (2009) · Science · doi:10.1126/science.1172447 · Cited by 934
Heritable genome editing in C. elegans via a CRISPR-Cas9 system
Friedland, A. E., Tzur, Y. B., Esvelt, K. M., Colaiácovo, M. P., Church, G. M., & Calarco, J. A. (2013) · Nature Methods · doi:10.1038/nmeth.2532 · Cited by 899 · cited 1×
“Recent strategies to tackle this challenge are relying on the use of genome editing tools such as ZFNs [2–7], TALENs [8–13] or more recently CRISPR-Cas system [14–17].”
MethodConditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
DuPage, M., Dooley, A. L., & Jacks, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.95 · Cited by 894
Lombardo, A., Genovese, P., Beausejour, C. M., Colleoni, S., Lee, Y.-L., Kim, K. A., Ando, D., Urnov, F. D., Galli, C., Gregory, P. D., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1353 · Cited by 845
Tissue- and site-specific DNA recombination in transgenic mice.
Orban, P. C., Chui, D., & Marth, J. D. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.15.6861 · Cited by 651
Targeted gene disruption in somatic zebrafish cells using engineered TALENs
Sander, J. D., Cade, L., Khayter, C., Reyon, D., Peterson, R. T., Joung, J. K., & Yeh, J.-R. J. (2011) · Nature Biotechnology · doi:10.1038/nbt.1934 · Cited by 620
Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors
Kafri, T., Blömer, U., Peterson, D. A., Gage, F. H., & Verma, I. M. (1997) · Nature Genetics · doi:10.1038/ng1197-314 · Cited by 605
Knockout rats generated by embryo microinjection of TALENs
Tesson, L., Usal, C., Ménoret, S., Leung, E., Niles, B. J., Remy, S., Santiago, Y., Vincent, A. I., Meng, X., Zhang, L., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1940 · Cited by 585
Efficient TALEN-mediated gene knockout in livestock
Carlson, D. F., Tan, W., Lillico, S. G., Stverakova, D., Proudfoot, C., Christian, M., Voytas, D. F., Long, C. R., Whitelaw, C. B. A., & Fahrenkrug, S. C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211446109 · Cited by 580
Recombinase-Mediated Gene Activation and Site-Specific Integration in Mammalian Cells
O'Gorman, S., Fox, D. T., & Wahl, G. M. (1991) · Science · doi:10.1126/science.1900642 · Cited by 572
Structural basis for CRISPR RNA-guided DNA recognition by Cascade
Jore, M. M., Lundgren, M., van Duijn, E., Bultema, J. B., Westra, E. R., Waghmare, S. P., Wiedenheft, B., Pul, Ü., Wurm, R., Wagner, R., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2019 · Cited by 562
Altering the Tropism of Lentiviral Vectors through Pseudotyping
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005) · Current Gene Therapy · doi:10.2174/1566523054546224 · Cited by 536
A phage integrase directs efficient site-specific integration in human cells
Groth, A. C., Olivares, E. C., Thyagarajan, B., & Calos, M. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090527097 · Cited by 495
Fok I dimerization is required for DNA cleavage
Bitinaite, J., Wah, D. A., Aggarwal, A. K., & Schildkraut, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10570 · Cited by 490
Effective gene therapy with nonintegrating lentiviral vectors
Yáñez-Muñoz, R. J., Balaggan, K. S., MacNeil, A., Howe, S. J., Schmidt, M., Smith, A. J., Buch, P., MacLaren, R. E., Anderson, P. N., Barker, S. E., et al. (2006) · Nature Medicine · doi:10.1038/nm1365 · Cited by 460
Thorpe, H. M., & Smith, M. C. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5505 · Cited by 430
Smith, J. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.17.3361 · Cited by 424
Construction of Transgenic Drosophila by Using the Site-Specific Integrase From Phage φC31
Groth, A. C., Fish, M., Nusse, R., & Calos, M. P. (2004) · Genetics · doi:10.1093/genetics/166.4.1775 · Cited by 423
Site-Specific Genomic Integration in Mammalian Cells Mediated by Phage φC31 Integrase
Thyagarajan, B., Olivares, E. C., Hollis, R. P., Ginsburg, D. S., & Calos, M. P. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3926-3934.2001 · Cited by 407
Development of a novel mouse glioma model using lentiviral vectors
Marumoto, T., Tashiro, A., Friedmann-Morvinski, D., Scadeng, M., Soda, Y., Gage, F. H., & Verma, I. M. (2009) · Nature Medicine · doi:10.1038/nm.1863 · Cited by 353
Schnell, M. A., Zhang, Y., Tazelaar, J., Gao, G.-P., Yu, Q. C., Qian, R., Chen, S.-J., Varnavski, A. N., LeClair, C., Raper, S. E., et al. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0330 · Cited by 342
Holkers, M., Maggio, I., Liu, J., Janssen, J. M., Miselli, F., Mussolino, C., Recchia, A., Cathomen, T., & Gonçalves, M. A. F. V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1446 · Cited by 312 · cited 1×
“TALENs have an important size with repeat domains hampering their vectorization [24].”
BackgroundTargeted gene knockout by direct delivery of zinc-finger nuclease proteins
Gaj, T., Guo, J., Kato, Y., Sirk, S. J., & Barbas, C. F. (2012) · Nature Methods · doi:10.1038/nmeth.2030 · Cited by 306
Integration Site for Streptomyces Phage φBT1 and Development of Site-Specific Integrating Vectors
Gregory, M. A., Till, R., & Smith, M. C. M. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.17.5320-5323.2003 · Cited by 302
Site-specific genomic integration produces therapeutic Factor IX levels in mice
Olivares, E. C., Hollis, R. P., Chalberg, T. W., Meuse, L., Kay, M. A., & Calos, M. P. (2002) · Nature Biotechnology · doi:10.1038/nbt753 · Cited by 286
Adenovirus gene transfer causes inflammation in the brain
Byrnes, A. P., Rusby, J. E., Wood, M. J. A., & Charlton, H. M. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00068-t · Cited by 276
A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination
Smith, A. J. H., De Sousa, M. A., Kwabi-Addo, B., Heppell-Parton, A., Impey, H., & Rabbitts, P. (1995) · Nature Genetics · doi:10.1038/ng0495-376 · Cited by 254
Development of Hyperactive Sleeping Beauty Transposon Vectors by Mutational Analysis
Zayed, H., Izsvák, Z., Walisko, O., & Ivics, Z. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.024 · Cited by 250
Philippe, S., Sarkis, C., Barkats, M., Mammeri, H., Ladroue, C., Petit, C., Mallet, J., & Serguera, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606197103 · Cited by 249 · cited 4×
“The vector plasmid pTrip-CMV-phic31-int-WPRE was derived from the plasmid pTrip-CMV-GFP-WPRE previously described [77] and the plasmid pCMV-phic31-int previously described [41] and kindly provided by M.”
MethodSelf-citationIntegration Specificity of Phage ϕC31 Integrase in the Human Genome
Chalberg, T. W., Portlock, J. L., Olivares, E. C., Thyagarajan, B., Kirby, P. J., Hillman, R. T., Hoelters, J., & Calos, M. P. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.098 · Cited by 237
Pfeifer, A., Brandon, E. P., Kootstra, N., Gage, F. H., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201415498 · Cited by 224
Directed evolution by in vitro compartmentalization
Miller, O. J., Bernath, K., Agresti, J. J., Amitai, G., Kelly, B. T., Mastrobattista, E., Taly, V., Magdassi, S., Tawfik, D. S., & Griffiths, A. D. (2006) · Nature Methods · doi:10.1038/nmeth897 · Cited by 210
Guo, J., Gaj, T., & Barbas, C. F. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.04.060 · Cited by 206
Structure of Fok I has implications for DNA cleavage
Wah, D. A., Bitinaite, J., Schildkraut, I., & Aggarwal, A. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10564 · Cited by 202
Belteki, G., Gertsenstein, M., Ow, D. W., & Nagy, A. (2003) · Nature Biotechnology · doi:10.1038/nbt787 · Cited by 186
Anton, M., & Graham, F. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4600-4606.1995 · Cited by 184
Morton, J., Davis, M. W., Jorgensen, E. M., & Carroll, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605633103 · Cited by 181
Directed evolution of the site specificity of Cre recombinase
Santoro, S. W., & Schultz, P. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022039799 · Cited by 172
Sustained somatic gene inactivation by viral transfer of Cre recombinase
Rohlmann, A., Gotthardt, M., Willnow, T., Hammer, R., & Herz, J. (1996) · Nature Biotechnology · doi:10.1038/nbt1196-1562 · Cited by 157
Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein Levels
Pruett-Miller, S. M., Reading, D. W., Porter, S. N., & Porteus, M. H. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000376 · Cited by 137
Transgenic Xenopus laevis embryos can be generated using φC31 integrase
Allen, B. G., & Weeks, D. L. (2005) · Nature Methods · doi:10.1038/nmeth814 · Cited by 131
In Vivo Correction of Murine Hereditary Tyrosinemia Type I by ϕC31 Integrase-Mediated Gene Delivery
Held, P. K., Olivares, E. C., Aguilar, C. P., Finegold, M., Calos, M. P., & Grompe, M. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.001 · Cited by 129
Site-specific recombination by φC31 integrase and other large serine recombinases
Smith, M. C. M., Brown, W. R., McEwan, A. R., & Rowley, P. A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380388 · Cited by 124
Andreas, S. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.11.2299 · Cited by 123
Creation of Engineered Human Embryonic Stem Cell Lines Using phiC31 Integrase
Thyagarajan, B., Liu, Y., Shin, S., Lakshmipathy, U., Scheyhing, K., Xue, H., Ellerström, C., Strehl, R., Hyllner, J., Rao, M. S., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0283 · Cited by 115
Genetic Analysis of Zinc-Finger Nuclease-Induced Gene Targeting in Drosophila
Bozas, A., Beumer, K. J., Trautman, J. K., & Carroll, D. (2009) · Genetics · doi:10.1534/genetics.109.101329 · Cited by 115
Directed evolution of a recombinase for improved genomic integration at a native human sequence
Sclimenti, C. R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.5044 · Cited by 109
Fish, M., Groth, A. C., Calos, M. P., & Nusse, R. (2007) · Nature Protocols · doi:10.1038/nprot.2007.328 · Cited by 109
Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration
Bertoni, C., Jarrahian, S., Wheeler, T. M., Li, Y., Olivares, E. C., Calos, M. P., & Rando, T. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504505102 · Cited by 107
Targeted Genome Modifications Using Integrase-deficient Lentiviral Vectors
Cornu, T. I., & Cathomen, T. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300345 · Cited by 105
Phage R4 integrase mediates site-specific integration in human cells
Olivares, E. C., Hollis, R. P., & Calos, M. P. (2001) · Gene · doi:10.1016/s0378-1119(01)00711-9 · Cited by 105
Hybrid Lentivirus-transposon Vectors with a Random Integration Profile in Human Cells
Staunstrup, N. H., Moldt, B., Mátés, L., Villesen, P., Jakobsen, M., Ivics, Z., Izsvák, Z., & Mikkelsen, J. G. (2009) · Molecular Therapy · doi:10.1038/mt.2009.10 · Cited by 96
φC31 Integrase-Mediated Nonviral Genetic Correction of Junctional Epidermolysis Bullosa
Ortiz-Urda, S., Thyagarajan, B., Keene, D. R., Lin, Q., Calos, M. P., & Khavari, P. A. (2003) · Human Gene Therapy · doi:10.1089/104303403765701204 · Cited by 94
φC31 Integrase Confers Genomic Integration and Long-Term Transgene Expression in Rat Retina
Chalberg, T. W., Genise, H. L., Vollrath, D., & Calos, M. P. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-1252 · Cited by 90
Molecular Analysis of Chromosomal Rearrangements in Mammalian Cells After ø C31-Mediated Integration
Ehrhardt, A., Engler, J. A., Xu, H., Cherry, A. M., & Kay, M. A. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.1077 · Cited by 86
Creating Designed Zinc-Finger Nucleases with Minimal Cytotoxicity
Ramalingam, S., Kandavelou, K., Rajenderan, R., & Chandrasegaran, S. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.043 · Cited by 84
Phage integrases for the construction and manipulation of transgenic mammals
Hollis, R. P., Stoll, S. M., Sclimenti, C. R., Lin, J., Chen-Tsai, Y., & Calos, M. P. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-79 · Cited by 78
Sleeping Beauty Transposition From Nonintegrating Lentivirus
Vink, C. A., Gaspar, H. B., Gabriel, R., Schmidt, M., McIvor, R. S., Thrasher, A. J., & Qasim, W. (2009) · Molecular Therapy · doi:10.1038/mt.2009.94 · Cited by 74
Non-Integrating Lentiviral Vectors
Sarkis, C., Philippe, S., Mallet, J., & Serguera, C. (2008) · Current Gene Therapy · doi:10.2174/156652308786848012 · Cited by 74
Self-citation390. Phage c31 Integrase Induces Chromosomal Aberrations in Primary Human Fibroblasts
Liu, J., Jeppesen, I., Nielsen, K., & Jensen, T. G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.08.451 · Cited by 72
φc31 integrase induces chromosomal aberrations in primary human fibroblasts
Liu, J., Jeppesen, I., Nielsen, K., & Jensen, T. G. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302789 · Cited by 67
Bolusani, S., Ma, C.-H., Paek, A. L., Konieczka, J. H., Jayaram, M., & Voziyanov, Y. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl548 · Cited by 59
Liu, J., Skjørringe, T., Gjetting, T., & Jensen, T. G. (2009) · BMC Biotechnology · doi:10.1186/1472-6750-9-31 · Cited by 51
Overexpression of caspase-9 triggers its activation and apoptosis in vitro.
Druskovic, M., Šuput, D., & Milisav, I. (2006) · PubMed · Cited by 51
Nakano, M., Odaka, K., Ishimura, M., Kondo, S., Tachikawa, N., Chiba, J., Kanegae, Y., & Saito, I. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.7.e40 · Cited by 50
Meredith, J. M., Underhill, A., McArthur, C. C., & Eggleston, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059264 · Cited by 46
Keravala, A., Portlock, J. L., Nash, J. A., Vitrant, D. G., Robbins, P. D., & Calos, M. P. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.928 · Cited by 46
Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase
Moldt, B., Staunstrup, N. H., Jakobsen, M., Yáñez-Muñoz, R. J., & Mikkelsen, J. G. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-60 · Cited by 44
Ehrhardt, A., Yant, S. R., Giering, J. C., Xu, H., Engler, J. A., & Kay, M. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300011 · Cited by 43
Ishikawa, Y., Tanaka, N., 村上, 和., Uchiyama, T., Kumaki, S., Tsuchiya, S., Kugoh, H., Oshimura, M., Calos, M. P., & Sugamura, K. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.891 · Cited by 41
Keravala, A., Chavez, C. L., Hu, G., Woodard, L. E., Monahan, P. E., & Calos, M. P. (2011) · Gene Therapy · doi:10.1038/gt.2011.31 · Cited by 38
Identification of pseudo attP sites for phage ϕC31 integrase in bovine genome
Ma, Q., Sheng, H., Yan, J., Cheng, S., Huang, Y., Chen-Tsai, Y., Ren, Z., Huang, S., & Zeng, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.04.145 · Cited by 37
Quantification of Zinc Finger Nuclease-Associated Toxicity
Cornu, T. I., & Cathomen, T. (2010) · Methods in Molecular Biology · doi:10.1007/978-1-60761-753-2_14 · Cited by 37
Portlock, J. L., Keravala, A., Bertoni, C., Lee, S., Rando, T. A., & Calos, M. P. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.871 · Cited by 28
Site-specific gene integration in cultured silkworm cells mediated by φC31 integrase
Nakayama, G., Kawaguchi, Y., Koga, K., & Kusakabe, T. (2005) · Molecular Genetics and Genomics · doi:10.1007/s00438-005-0026-3 · Cited by 28
Using phiC31 integrase to make transgenic Xenopus laevis embryos
Allen, B. G., & Weeks, D. L. (2006) · Nature Protocols · doi:10.1038/nprot.2006.183 · Cited by 27
Tay, Y., Ho, C. E. H., Dröge, P., & Ghadessy, F. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1089 · Cited by 26
Chavez, C. L., Keravala, A., Chu, J. N., Farruggio, A. P., Cuéllar, V. E., Voorberg, J., & Calos, M. P. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.110 · Cited by 22
Activities of Various FLP Recombinases Expressed by Adenovirus Vectors in Mammalian Cells
Kondo, S., Takata, Y., Nakano, M., Saito, I., & Kanegae, Y. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.04.057 · Cited by 21
Gene therapy of epidermolysis bullosa
Bauer, J. W., & Laimer, M. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.9.1435 · Cited by 21
Kolot, M. N., Meroz, A., & Yagil, E. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10747 · Cited by 20
Grandchamp, N., Henriot, D., Philippe, S., Amar, L., Ursulet, S., Serguera, C., Mallet, J. J., & Sarkis, C. (2011) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-9-1 · Cited by 19
Self-citationUse of Phage PhiC31 Integrase as a Tool for Zebrafish Genome Manipulation
Lister, J. A. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-374814-0.00011-2 · Cited by 16
Pointing fingers at the limiting step in gene targeting
Wilson, J. H. (2003) · Nature Biotechnology · doi:10.1038/nbt0703-759 · Cited by 13
Efficacy and Site-Specificity of Adenoviral Vector Integration Mediated by the Phage φC31 Integrase
Robert, M.-A., Zeng, Y., Raymond, B., Desfossé, L., Mairey, É., Tremblay, J. P., Bernard Massie, B., & Gilbert, R. (2012) · Human Gene Therapy Methods · doi:10.1089/hgtb.2012.122 · Cited by 7
Research works printed but not linked: 1
- Moldt B, Staunstrup NH, Jakobsen M, Yáñez-Muñoz RJ, Mikkelsen JG (2008) Genomic insertion of lentiviral DNA circles directed by the yeast Flp recombinase. BMC Biotechnol 8: 60 10.1186/1472-6750-8-60 18691430 PMC2538528 · DOI · Paper page
Cited by
Clinical use of lentiviral vectors
Milone, M. C., & O’Doherty, U. (2018) · Leukemia · doi:10.1038/s41375-018-0106-0 · Cited by 930
“To allow for long-term expression in dividing cells, a dual NILV vector system was developed to include the integrase of phage phiC31 [91].”
MethodGenetic switches designed for eukaryotic cells and controlled by serine integrases
Gomide, M. D. S., Sales, T. T., Barros, L. R. C., Limia, C. E. G., de Oliveira, M. A., Florentino, L. H., Barros, L. M. G., Robledo, M. L., José, G. P. C., Almeida, M. S. M., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-0971-8 · Cited by 31
Chen, Y., Zhao, J., Luo, Y., Wang, Y., & Jiang, Y. (2016) · Oncology Reports · doi:10.3892/or.2016.5047 · Cited by 17
Prospect and progress of gene therapy in treating atherosclerosis
Kivelä, A. M., Huusko, J., & Ylä‐Herttuala, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1084282 · Cited by 12
Cystic fibrosis: A look into the future of prenatal screening and therapy
Nishida, K., Smith, Z., Rana, D., Palmer, J., & Gallicano, G. I. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21091 · Cited by 9
Metadata
- Authors
- Grandchamp, N., Altémir, D., Philippe, S., Ursulet, S., Pilet, H., Serre, M.-C., Lenain, A., Serguera, C., Mallet, J., & Sarkis, C.
- Affiliations
- Inserm (FR)
- Laboratoire de Virologie Moléculaire et Structurale (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Sarkis, Chamsy
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-23
- Volume
- 9
- Issue
- 6
- Pages
- e99649
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4067480
- OpenAlex
- W1983795781
- Cited by
- 11
- References
- 98
- Citations by year
- 2026: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 2 · 2014: 1
- FWCI
- 1.31
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- lentiviral vectors, phiC31 integrase, site-specific recombination, attP site, attB site, DNA damage, insertional mutagenesis, transgenesis, stable gene expression
- MeSH terms
- Animals, Attachment Sites, Microbiological, Bacteriophages, Base Sequence, Cell Line, DNA Damage, Genetic Vectors, Humans, Hybridization, Genetic, Models, Biological, Molecular Sequence Data, Recombination, Genetic, Lentivirus, Polymerase Chain Reaction, Mutagenesis, Insertional, Nuclear Localization Signals, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.